Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sebastien Gouard"'
Autor:
Loris Roncali, Séverine Marionneau-Lambot, Charlotte Roy, Romain Eychenne, Sébastien Gouard, Sylvie Avril, Nicolas Chouin, Jérémie Riou, Mathilde Allard, Audrey Rousseau, François Guérard, François Hindré, Michel Chérel, Emmanuel Garcion
Publikováno v:
EBioMedicine, Vol 105, Iss , Pp 105202- (2024)
Summary: Background: Glioblastoma (GB), the most aggressive brain cancer, remains a critical clinical challenge due to its resistance to conventional treatments. Here, we introduce a locoregional targeted-α-therapy (TAT) with the rat monoclonal anti
Externí odkaz:
https://doaj.org/article/c893b207ab6f4738b36ea397dd0319b1
Autor:
Daniela Leonetti, Hala Estephan, Natacha Ripoche, Nolwenn Dubois, Audrey Aguesse, Sebastien Gouard, Lisa Brossard, Sophie Chiavassa, Isabelle Corre, Michel Neunlist, Elie Hadchity, Marie-Hélène Gaugler, Maxime Mahé, francois Paris
Publikováno v:
Cancer Research
Cancer Research, 2020
HAL
Cancer Research, American Association for Cancer Research, 2020
Cancer Research, 2020
HAL
Cancer Research, American Association for Cancer Research, 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0ae2e1390c6d9da2ebfd0df99fe0b4d4
https://www.hal.inserm.fr/inserm-02539662
https://www.hal.inserm.fr/inserm-02539662
Autor:
Judith Anna Delage, Silvano Gnesin, John O. Prior, Jacques Barbet, Patricia Le Saëc, Séverine Marionneau-Lambot, Sébastien Gouard, Michel Chérel, Mickael Bourgeois, Niklaus Schaefer, David Viertl, Julie Katrin Fierle, Steven Mark Dunn, Alain Faivre-Chauvet
Publikováno v:
Cancers, Vol 13, Iss 23, p 5936 (2021)
1C1m-Fc, a promising anti-TEM-1 DOTA conjugate, was labeled with 64Cu to target cancer cells for PET imaging and predicting the efficacy and safety of a previously studied [177Lu]Lu-1C1m-Fc companion therapy. DOTA-conjugated 1C1m-Fc was characterized
Externí odkaz:
https://doaj.org/article/8a3bbf681cfe4069b13366e861a99520
Autor:
Marisa Capitao, Justine Perrin, Sylvain Simon, Sébastien Gouard, Nicolas Chouin, Frank Bruchertseifer, Alfred Morgenstern, Latifa Rbah-Vidal, Michel Chérel, Emmanuel Scotet, Nathalie Labarrière, Yannick Guilloux, Joëlle Gaschet
Publikováno v:
Cancers, Vol 13, Iss 6, p 1256 (2021)
PD-L1 (programmed death-ligand 1, B7-H1, CD274), the ligand for PD-1 inhibitory receptor, is expressed on various tumors, and its expression is correlated with a poor prognosis in melanoma. Anti-PD-L1 mAbs have been developed along with anti-CTLA-4 a
Externí odkaz:
https://doaj.org/article/ad86c55c5fbd456fa984042dd8141ee7
Autor:
Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, Delphine Dansette, Clément Bailly, François Guérard, Nicolas Chouin, Ferid Haddad, Cyril Alliot, Joëlle Gaschet, Romain Eychenne, Françoise Kraeber-Bodéré, Michel Chérel
Publikováno v:
Cancers, Vol 12, Iss 9, p 2721 (2020)
Despite therapeutic progress in recent years with the introduction of targeted therapies (daratumumab, elotuzumab), multiple myeloma remains an incurable cancer. The question is therefore to investigate the potential of targeted alpha therapy, combin
Externí odkaz:
https://doaj.org/article/2e4d22a2ffbb4a3cb77aaa9418d641c5
Autor:
Clément Bailly, Benjamin Chalopin, Sébastien Gouard, Thomas Carlier, Patricia Remaud-Le Saëc, Séverine Marionneau-Lambot, Philippe Moreau, Cyrille Touzeau, Françoise Kraeber-Bodere, Caroline Bodet-Milin, Michel Chérel
Publikováno v:
Cancers, Vol 12, Iss 6, p 1467 (2020)
Despite constant progress over the past three decades, multiple myeloma (MM) is still an incurable disease, and the identification of new biomarkers to better select patients and adapt therapy is more relevant than ever. Recently, the introduction of
Externí odkaz:
https://doaj.org/article/0fdfd3910eb7403c97984bdf453efc7f
Autor:
Jean-Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, Catherine Maurel, Yannick Guilloux, Alain Faivre-Chauvet, Alfred Morgenstern, Frank Bruchertseifer, Michel Chérel, François Davodeau, Joëlle Gaschet
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 16, Iss 4, Pp 319-328 (2014)
Radioimmunotherapy (RIT) is a therapeutic modality that allows delivering of ionizing radiation directly to targeted cancer cells. Conventional RIT uses β-emitting radioisotopes, but recently, a growing interest has emerged for the clinical developm
Externí odkaz:
https://doaj.org/article/256472fb83534cd293b09b0b436d237a
Autor:
Clément Bailly, Caroline Bodet-Milin, Mickaël Bourgeois, Sébastien Gouard, Catherine Ansquer, Matthieu Barbaud, Jean-Charles Sébille, Michel Chérel, Françoise Kraeber-Bodéré, Thomas Carlier
Publikováno v:
Cancers, Vol 11, Iss 9, p 1282 (2019)
Personalized medicine represents a major goal in oncology. It has its underpinning in the identification of biomarkers with diagnostic, prognostic, or predictive values. Nowadays, the concept of biomarker no longer necessarily corresponds to biologic
Externí odkaz:
https://doaj.org/article/405b3813e3114d6ca80092cc8ece06d8
Autor:
Clément Bailly, Sébastien Gouard, François Guérard, Benjamin Chalopin, Thomas Carlier, Alain Faivre-Chauvet, Patricia Remaud-Le Saëc, Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah-Vidal, Raphaël Tripier, Ferid Haddad, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Michel Chérel
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 10, p 2564 (2019)
Although positron emission tomography (PET) imaging with 18-Fluorodeoxyglucose (18F-FDG) is a promising technique in multiple myeloma (MM), the development of other radiopharmaceuticals seems relevant. CD138 is currently used as a standard marker for
Externí odkaz:
https://doaj.org/article/122cd9e6f42646f0947532ad87f73e51
Autor:
Laëtitia Dorso, Edith Bigot-Corbel, Jérôme Abadie, Maya Diab, Sébastien Gouard, Frank Bruchertseifer, Alfred Morgenstern, Catherine Maurel, Michel Chérel, François Davodeau
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151330 (2016)
Short-term toxicological evaluations of alpha-radioimmunotherapy have been reported in preclinical assays, particularly using bismuth-213 (213Bi). Toxicity is greatly influenced not only by the pharmacokinetics and binding specificity of the vector b
Externí odkaz:
https://doaj.org/article/6b9082b483f14a40be2de1e420330e30